Evidence-Based Information on the Clinical Use of Neurofeedback for ADHD

Show simple item record

dc.contributor Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.author MORIYAMA, Tais S. FMUSP-HC
CAYE, Arthur
ROHDE, Luis A.
dc.date.issued 2012
dc.identifier.citation NEUROTHERAPEUTICS, v.9, n.3, p.588-598, 2012
dc.identifier.issn 1933-7213
dc.identifier.uri http://observatorio.fm.usp.br/handle/OPI/1061
dc.description.abstract Neurofeedback (NF) is a training to enhance self-regulatory capacity over brain activity patterns and consequently over brain mental states. Recent findings suggest that NF is a promising alternative for the treatment of attention-deficit/hyperactivity disorder (ADHD). We comprehensively reviewed literature searching for studies on the effectiveness and specificity of NF for the treatment of ADHD. In addition, clinically informative evidence-based data are discussed. We found 3 systematic review on the use of NF for ADHD and 6 randomized controlled trials that have not been included in these reviews. Most nonrandomized controlled trials found positive results with medium-to-large effect sizes, but the evidence for effectiveness are less robust when only randomized controlled studies are considered. The direct comparison of NF and sham-NF in 3 published studies have found no group differences, nevertheless methodological caveats, such as the quality of the training protocol used, sample size, and sample selection may have contributed to the negative results. Further data on specificity comes from electrophysiological studies reporting that NF effectively changes brain activity patterns. No safety issues have emerged from clinical trials and NF seems to be well tolerated and accepted. Follow-up studies support long-term effects of NF. Currently there is no available data to guide clinicians on the predictors of response to NF and on optimal treatment protocol. In conclusion, NF is a valid option for the treatment for ADHD, but further evidence is required to guide its use.
dc.description.sponsorship · Brazilian National Counsel of Technological and Scientific Development (CNPq) [483934/2010-0]
· Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Brazil
dc.language.iso eng
dc.publisher SPRINGER
dc.relation.ispartof Neurotherapeutics
dc.rights restrictedAccess
dc.subject Attention-deficit/hyperactivity disorder (ADHD); Neurofeedback; Biofeedback; Slow cortical potential; Theta/Beta training
dc.subject.other attention-deficit/hyperactivity-disorder; deficit hyperactivity disorder; slow cortical potentials; randomized controlled-trial; eeg biofeedback; follow-up; selective attention; anterior cingulate; stimulant-drugs; treating ad/hd
dc.title Evidence-Based Information on the Clinical Use of Neurofeedback for ADHD
dc.type article
dc.rights.holder Copyright SPRINGER
dc.description.group LIM/21
dc.identifier.doi 10.1007/s13311-012-0136-7
dc.identifier.pmid 22930416
dc.type.category original article
dc.type.version publishedVersion
hcfmusp.author MORIYAMA, Tais S.:HC:IPQ
hcfmusp.author POLANCZYK, Guilherme:FM:MPS
hcfmusp.author.external · CAYE, Arthur:Univ Fed Rio Grande do Sul, Child Psychiat Div, Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil
· BANASCHEWSKI, Tobias:Univ Heidelberg, Dept Child & Adolescent Psychiat & Psychotherapy, Cent Inst Mental Hlth, Med Fac Mannheim, D-6800 Mannheim, Germany
· BRANDEIS, Daniel:Univ Zurich, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland; Univ Zurich, Dept Child & Adolescent Psychiat, Zurich, Switzerland; Univ Heidelberg, Dept Child & Adolescent Psychiat & Psychotherapy, Cent Inst Mental Hlth, Med Fac Mannheim, D-6800 Mannheim, Germany
· ROHDE, Luis A.:Hosp Clin Porto Alegre, Serv Psiquiatria Infancia & Adolescencia, Porto Alegre, RS, Brazil; INCT CNPq, Natl Inst Dev Psychiat Children & Adolescents, Sao Paulo, Brazil
hcfmusp.origem.id 2-s2.0-84866458084
hcfmusp.origem.id WOS:000308826800010
hcfmusp.publisher.city NEW YORK
hcfmusp.publisher.country USA
hcfmusp.relation.reference · Arnold LE, 2012, J ATTEN DISORD, DOI [10.1177/1087054712446173, DOI 10.1177/1087054712446173]
· Arns M, 2009, CLIN EEG NEUROSCI, V40, P180
· Bakhshayesh AR, 2011, EUR CHILD ADOLES PSY, V20, P481, DOI 10.1007/s00787-011-0208-y
· Banaschewski T, 2004, J NEURAL TRANSM, V111, P841, DOI 10.1007/s00702-003-0040-8
· Banaschewski T, 2007, J CHILD PSYCHOL PSYC, V48, P415, DOI 10.1111/j.1469-7610.2006.01681.x
· Banaschewski T, 2003, J CHILD PSYCHOL PSYC, V44, P356, DOI 10.1111/1469-7610.00127
· Barkley RA, 1996, PEDIATRICS, V98, P1089
· Beauregard M, 2006, APPL PSYCHOPHYS BIOF, V31, P3, DOI 10.1007/s10484-006-9001-y
· Berger H, 1929, ARCH PSYCHIAT NERVEN, V87, P527, DOI 10.1007/BF01797193
· Biederman J, 2004, INT J NEUROPSYCHOPH, V7, P77, DOI 10.1017/S1461145703003973
· Brandeis D, 2011, CLIN NEUROPHYSIOL, V122, P856, DOI 10.1016/j.clinph.2010.08.011
· Liechti MD, 2012, CLIN NEUROPHYSIOL, V123, P1989, DOI 10.1016/j.clinph.2012.03.016
· Cannon R, 2007, INT J NEUROSCI, V117, P337, DOI 10.1080/00207450500514003
· Cannon R, 2009, INT J NEUROSCI, V119, P404, DOI 10.1080/00207450802480325
· Clarke AR, 2011, CLIN NEUROPHYSIOL, V122, P1333, DOI 10.1016/j.clinph.2010.12.038
· Cortoos A, 2010, APPL PSYCHOPHYS BIOF, V35, P125, DOI 10.1007/s10484-009-9116-z
· Debeus R, 2011, NEUROFEEDBACK NEUROM, P128
· Doehnert M, 2008, J NEURAL TRANSM, V115, P1445, DOI 10.1007/s00702-008-0104-x
· Drechsler R, 2011, BEFUNDE Z NEUROPSYCH, V22, P131
· Drechsler R, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-35
· Faraone SV, 2006, PSYCHOL MED, V36, P159, DOI 10.1017/S003329170500471X
· Fuchs T, 2003, APPL PSYCHOPHYS BIOF, V28, P1, DOI 10.1023/A:1022353731579
· Gani C, 2008, INT J BIOELECTROMAGN, V10, P209
· Gevensleben H, 2010, EUR CHILD ADOLES PSY, V19, P715, DOI 10.1007/s00787-010-0109-5
· Gevensleben H, 2009, INT J PSYCHOPHYSIOL, V74, P149, DOI 10.1016/j.ijpsycho.2009.08.005
· Gevensleben H, 2009, J CHILD PSYCHOL PSYC, V50, P780, DOI 10.1111/j.1469-7610.2008.02033.x
· Hazell PL, 2009, J AM ACAD CHILD PSY, V48, P461, DOI 10.1097/CHI.0b013e31819c242f
· Heinrich H, 2004, BIOL PSYCHIAT, V55, P772, DOI 10.1016/j.biopsych.2003.11.013
· Holtmann M, 2009, KINDH ENTWICKL, V18, P95, DOI 10.1026/0942-5403.18.2.95
· Kaiser D. A., 2000, J NEUROTHERAPY, V4, P5, DOI 10.1300/J184v04n01_02
· Kamiya J, 1968, PSYCHOL TODAY, V1, P56
· Kayiran S, 2010, APPL PSYCHOPHYS BIOF, V35, P293, DOI [10.1007/s10484-010-9135-9, 10.1007/s10484.010.9135.9]
· Klassen AF, 2004, PEDIATRICS, V114, pE541, DOI 10.1542/peds.2004-0844
· Kropotov JD, 2005, INT J PSYCHOPHYSIOL, V55, P23, DOI 10.1016/j.ijpsycho.2004.05.011
· Lahey BB, 2004, AM J PSYCHIAT, V161, P2014, DOI 10.1176/appi.ajp.161.11.2014
· Lansbergen MM, 2011, J NEURAL TRANSM, V118, P275, DOI 10.1007/s00702-010-0524-2
· Leins U, 2007, APPL PSYCHOPHYS BIOF, V32, P73, DOI 10.1007/s10484-007-9031-0
· Levesque J, 2006, NEUROSCI LETT, V394, P216, DOI 10.1016/j.neulet.2005.10.100
· Linden M, 1996, BIOFEEDBACK SELF-REG, V21, P35, DOI 10.1007/BF02214148
· Lofthouse N, 2012, J ATTEN DISORD, V16, P351, DOI 10.1177/1087054711427530
· Logemann HNA, 2010, NEUROSCI LETT, V479, P49, DOI 10.1016/j.neulet.2010.05.026
· LUBAR JF, 1976, BIOFEEDBACK SELF-REG, V1, P293, DOI 10.1007/BF01001170
· Mayer K, 2012, J NEUROTHER, V16, P37
· McGough J, 2006, J AM ACAD CHILD PSY, V45, P1314, DOI 10.1097/01.chi.0000235083.40285.08
· MILLER NE, 1969, SCIENCE, V163, P434, DOI 10.1126/science.163.3866.434
· Molina BSG, 2009, J AM ACAD CHILD PSY, V48, P484, DOI 10.1097/CHI.0b013e31819c23d0
· Monastra VJ, 2002, APPL PSYCHOPHYS BIOF, V27, P231, DOI 10.1023/A:1021018700609
· Perreau-Linck E, 2010, J NEUROTHERAPY, V14, P229
· Polanczyk G, 2007, AM J PSYCHIAT, V164, P942, DOI 10.1176/appi.ajp.164.6.942
· Rossiter T, 2004, APPL PSYCHOPHYS BIOF, V29, P233, DOI 10.1007/s10484-004-0383-4
· Rossiter T, 2004, APPL PSYCHOPHYS BIOF, V29, P95, DOI 10.1023/B:APBI.0000026636.13180.b6
· Rossiter TR, 1995, J NEUROTHERAPY, Vxx, P48
· Sherlin LH, 2011, J NEUROTHER, V15, P292
· SHOUSE MN, 1979, BIOFEEDBACK SELF-REG, V4, P299, DOI 10.1007/BF00998960
· Steiner NJ, 2011, CLIN PEDIATR, V50, P615, DOI 10.1177/0009922810397887
· STERMAN MB, 1974, EPILEPSIA, V15, P395, DOI 10.1111/j.1528-1157.1974.tb04016.x
· STERMAN MB, 1978, EXP NEUROL, V62, P735, DOI 10.1016/0014-4886(78)90281-9
· Sterman MB, 2006, APPL PSYCHOPHYS BIOF, V31, P21, DOI 10.1007/s10484-006-9002-x
· Strehl U, 2006, PEDIATRICS, V118, pE1530, DOI 10.1542/peds.2005-2478
· Tan G, 2009, CLIN EEG NEUROSCI, V40, P173
· Thompson L, 1998, APPL PSYCHOPHYS BIOF, V23, P243, DOI 10.1023/A:1022213731956
· Thornton KE, 2008, APPL PSYCHOPHYS BIOF, V33, P101, DOI 10.1007/s10484-008-9056-z
· Vitiello B, 2007, J CHILD ADOL PSYCHOP, V17, P593, DOI 10.1089/cap.2007.0058
· Wangler C, 2011, BIOORGAN MED CHEM, V19, P3864, DOI 10.1016/j.bmc.2010.12.047
· Wangler S, 2011, CLIN NEUROPHYSIOL, V122, P942, DOI 10.1016/j.clinph.2010.06.036
dc.description.index MEDLINE
hcfmusp.citation.scopus 64
hcfmusp.citation.wos 56
hcfmusp.affiliation.country Brasil
hcfmusp.affiliation.country Alemanha

Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


My Account